{"contentid": 488631, "importid": NaN, "name": "Caris Life Sciences raises $830 million in growth equity capital", "introduction": "Texas, USA-based molecular science and artificial intelligence (AI) focused Caris Life Sciences has announced an $830 million growth equity round at a post-money valuation of $7.83 billion.", "content": "<p>Texas, USA-based molecular science and artificial intelligence (AI) focused Caris Life Sciences has announced an $830 million growth equity round at a post-money valuation of $7.83 billion.</p>\n<p>With this investment, Caris has raised approximately $1.3 billion 0in external financing since 2018. This financing represents one of the largest capital raises in precision medicine and includes a diverse syndicate of leading investors.</p>\n<p>This is not only the biggest private company financing of the year and the third biggest to date in the medtech industry &ndash; it also catapults the firm up the rankings of the companies that have raised the most in total.</p>\n<p>The round was led by Sixth Street, a leading global investment firm making its third investment in Caris since 2018.</p>\n<p>The Caris Molecular Intelligence approach allows oncologists to assess all 22,000 genes in both DNA and RNA, utilizing whole exome sequencing, whole transcriptome sequencing, protein analysis, and proprietary AI models and signatures. This powerful combination delivers the most comprehensive and clinically relevant profiling available on the market.</p>\n<p>As demand for personalized cancer care is expanding worldwide, patients and physicians seek to better understand their specific cancers to develop customized treatment plans that ultimately lead to better outcomes. This financing provides Caris with strategic capital for continued commercial expansion and investment toward delivering a first-in-class liquid biopsy platform with high concordance to tissue across different modalities including therapy selection, recurrence monitoring and early screening across all cancer types.</p>\n<p>\"Caris puts the patient at the center of everything we do. This recent raise will help us bring our market-leading science and technologies to as many patients as possible, ultimately reinventing cancer care,\" said David Halbert, chairman and chief executive of Caris Life Sciences, adding: \"We plan to unlock the full potential of precision medicine through comprehensive interrogation of cancer at the molecular level. This will allow the delivery of transformative applications of molecular science,&nbsp;including the launch of our early detection (stage 1 and stage 2) blood-based pan-cancer test, providing results for every patient with no non-shedders.\"</p>", "date": "2021-05-14 10:19:00", "meta_title": "Caris Life Sciences raises $830 million in growth equity capital", "meta_keywords": "Caris Life Sciences, Financing, Equity capital, Personalized medicine, Sixth Street", "meta_description": "Caris Life Sciences raises $830 million in growth equity capital", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-05-14 09:49:00", "updated": "2021-05-14 10:19:02", "access": NaN, "url": "https://www.thepharmaletter.com/article/caris-life-sciences-raises-830-million-in-growth-equity-capital", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "caris_big.png", "image2id": "caris_small.png", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Oncology", "topic_tag": "Business Financing", "geography_tag": "USA", "company_tag": "Caris Life Sciences", "drug_tag": NaN, "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-05-14 10:19:00"}